- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03725397
Inpatient Versus Outpatient Foley Cervical Ripening Study
February 21, 2023 updated by: Yale University
To compare the efficacy and safety of cervical ripening with transcervical Foley catheter in inpatient vs outpatient setting
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of the current study is to compare the efficacy and safety of cervical ripening with transcervical Foley catheter in inpatient vs outpatient setting in a diverse, urban population within the United States.
We hypothesize that there will be no differences in time-to-delivery, failed induction rates, cesarean section rates, or maternal/neonatal morbidity and that there will be no differences in total length of stay (LOS), hours of sleep, active labor duration, and perceived satisfaction between groups.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale New Haven Hospital, York Street Campus
-
New Haven, Connecticut, United States, 06511
- Yale New Haven Hospital- St. Raphael
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Indication for Induction of Labor is present
- Gestational age > 37 completed weeks with absence of comorbidities with an optimal dating (ultrasonography was performed before 22 weeks gestation)
- Singleton fetus in cephalic presentation confirmed with an ultrasound at the time of presentation for induction of labor
- Cervical exam with Bishop Score <6
- Intact membranes
- Normal vital signs (blood pressure < 140/90, normal body temperature) at the time of presentation for Induction of Labor and within the last 24 hours
- Maternal age ≥18 years of age
Exclusion Criteria:
- Any contraindication for vaginal birth by institutional policy
- Multiple gestation
- History of cesarean delivery
- Oligohydramnios/polyhydramnios/anhydramnios (MVP <2cm)
- Rupture of membranes
- Poorly controlled diabetes (Hgb A1C>8% and/or fingerstick glucose above target >50% of the time in the past week)
- Poorly controlled chronic hypertension, gestational hypertension or preeclampsia (patient requiring IV antihypertensives within 4 hours of arrival)
- Vaginal bleeding
- Any conditions that require continuous electronic fetal monitoring either by institutional policy or provider determination (intrahepatic cholestasis of pregnancy, intrauterine growth restriction, abnormal non-stress test, others)
- Fetal anomaly with anticipated neonatal intensive care unit admission
- Fetal demise
- HIV infection, presence of genital herpetic lesion
- History of substance abuse during this pregnancy
- History of precipitous delivery (delivery <3hrs from onset of labor)
- Poor access to care (social, distance to hospital > 45 min, limited transportation)
- Poor social situation, history of domestic violence, untreated/uncontrolled psychiatric condition
- Inability to give informed consent, history of mental retardation
- Strong preference for inpatient management
- Inability to understand English or Spanish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Outpatients with a transcervical Foley catheter
Women with a transcervical Foley catheter in place that will spend the night at home.
|
The offered (studied) intervention will be allowing the women with a transcervical Foley catheter in place to spend the night at home.
|
Active Comparator: Inpatients with a transcervical Foley catheter
Women to be admitted to the hospital overnight which has been a "standard of care".
|
Women with a transcervical Foley catheter to be admitted to the hospital overnight which has been a "standard of care".
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time of Foley catheter extrusion
Time Frame: within 24 hours
|
Antepartum time of Foley catheter extrusion before patient being brought to labor
|
within 24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bishop score
Time Frame: during labor
|
Bishop scoring system used to consider having cervical ripening.Women with favorable cervices (BS 8 or more) are considered to have a cervix ripe and ready to proceed to induction.
BS <6 are considered unripe, and therefore may benefit from additional ripening modalities
|
during labor
|
Total time in cervical ripening
Time Frame: from labor induction to delivery time
|
Measure of total time in cervical ripening
|
from labor induction to delivery time
|
Total time slept during pre-induction
Time Frame: during labor
|
Total time slept during pre-induction
|
during labor
|
Total time in hospital
Time Frame: no max but an average of 3 days
|
Total time in hospital
|
no max but an average of 3 days
|
Analgesia used during pre-induction
Time Frame: within 24 hours before Pitocin initiation
|
Analgesia used during pre-induction
|
within 24 hours before Pitocin initiation
|
Use of oxytocin
Time Frame: 3 days
|
Pitocin is given as a continuous infusion and the dose is titrated according to the contraction pattern (goal max contractions but not hyperstimulation).
We will calculate the total time of Pitocin infusion as well as total dose (rate of infusion x time).
|
3 days
|
Fever over 38 degrees C
Time Frame: within 7 days of Foley placement
|
Did the patient have a fever over 38 degrees C
|
within 7 days of Foley placement
|
Neonatal Intensive Care Unit (NICU)
Time Frame: within 7 days of Foley placement
|
Was the baby admitted to NICU
|
within 7 days of Foley placement
|
APGAR scores
Time Frame: 1 minute of life
|
Apgar score is a universal (international) scoring system.
The 1-minute score determines how well the baby tolerated the birthing process.
The 5-minute score tells the health care provider how well the baby is doing outside the mother's womb.
|
1 minute of life
|
APGAR scores
Time Frame: 5 minutes of life
|
Apgar score is a universal (international) scoring system.
The 1-minute score determines how well the baby tolerated the birthing process.
The 5-minute score tells the health care provider how well the baby is doing outside the mother's womb.
|
5 minutes of life
|
Hospital charges
Time Frame: within 30 days after discharge
|
All patients will be charged.
We are hoping to see lower charges for women in the Out Patient group.
|
within 30 days after discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Katherine Kohari, MD, Yale University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 8, 2019
Primary Completion (Actual)
June 27, 2022
Study Completion (Actual)
June 27, 2022
Study Registration Dates
First Submitted
June 22, 2018
First Submitted That Met QC Criteria
October 29, 2018
First Posted (Actual)
October 31, 2018
Study Record Updates
Last Update Posted (Estimate)
February 22, 2023
Last Update Submitted That Met QC Criteria
February 21, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2000022710
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induced; Birth
-
Alexandra Hospital, Athens, GreeceNational and Kapodistrian University of AthensCompletedLabor, Induced | Induced; BirthGreece
-
Oslo Metropolitan UniversityVestre Viken Hospital Trust; Oslo University HospitalCompletedLabor, Induced | Induced; BirthNorway
-
Cairo UniversityCompleted
-
Brigham and Women's HospitalCompleted
-
Washington University School of MedicineRecruiting
-
Rambam Health Care CampusCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingPregnancy | Induced; BirthFrance
-
University Hospital, ToursCompletedDelivery Uterine | Birth; InducedFrance
-
Hurley Medical CenterRecruitingInduced; Birth | Induced Vaginal DeliveryUnited States
-
Montefiore Medical CenterTerminated
Clinical Trials on Outpatient
-
Connolly Hospital BlanchardstownCompletedOutpatients General Surgery Virtual ClinicIreland
-
Quality Living, Inc.Enrolling by invitationBrain Injuries, TraumaticUnited States
-
PerspectumGE HealthcareCompletedEndometriosis | Reproductive System DisorderUnited Kingdom
-
Centre Hospitalier Régional Metz-ThionvilleCompleted
-
Zealand University HospitalUnknownOutpatient | Hemithyroidectomy | HemmorhageDenmark
-
PerspectumRecruitingBreast Cancer | Breast DiseasesUnited Kingdom
-
Queen's University, BelfastCompletedPatients at High Risk of Medicine-related ProblemsUnited Kingdom
-
Rovere Querini PatriziaASST Fatebenefratelli Sacco; ASST Grande Ospedale Metropolitano NiguardaRecruitingHeart Failure | Pneumonia | Hypertension | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Urinary Tract Infections | Deep Vein Thrombosis | Fever of Unknown OriginItaly
-
Leiden University Medical CenterNot yet recruitingSystemic Sclerosis
-
Centre Hospitalier Universitaire de NiceRecruiting